Erector Spinae Plane Block in Scoliotic Adolescents
Primary Purpose
Scoliosis Idiopathic, Scoliosis; Adolescence, Erector Spinae Plane Block
Status
Completed
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
Erector Spinae Plane Block
Fentanyl
additional Fentanyl
Morphine
rescue Morphine
pethidine
Ketorolac
Acetaminophen
Sponsored by
About this trial
This is an interventional supportive care trial for Scoliosis Idiopathic
Eligibility Criteria
Inclusion Criteria:
- American society of Anesthesia classification (ASA) I-II
- Patients undergoing dorsal spine instrumentation for scoliosis.
Exclusion Criteria:
- Refusal of block.
- Bleeding tendency with prothrombin concentration PC less than 75 % or platelet count less than 150,000/µL.
- Skin lesion, wounds or infection at the puncture site.
- Known allergy to local anaesthetic drugs.
Sites / Locations
- Cairo University Hospitals
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Other
Arm Label
Group E
Group C
Arm Description
patients will receive Erector Spinae plane block in addition to intravenous fentanyl
Control group will receive only intravenous fentanyl.
Outcomes
Primary Outcome Measures
Total morphine consumption
Total postoperative rescue morphine consumption in mg/kg for each group in the first 24 hours post-operative period.
Secondary Outcome Measures
Total fentanyl consumption
Total intraoperative fentanyl consumption in mcg/kg for each group.
Visual Analogue Scale
the visual analogue scale (VAS) is for Pain assessment It is a * total 10 cm * linear scale for pain it ranges from minimum ( 0 for no pain at all ) to maximum ( 10 for the worst pain imaginable ) higher number values indicate worst outcome. For example, as the patient mark the scale nearer to maximum, this indicate more severe pain.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03968146
Brief Title
Erector Spinae Plane Block in Scoliotic Adolescents
Official Title
Ultrasound Guided Erector Spinae Plane Block in Scoliotic Adolescents Undergoing Posterior Spine Instrumentation . A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Completed
Study Start Date
June 18, 2019 (Actual)
Primary Completion Date
November 5, 2019 (Actual)
Study Completion Date
December 2, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kasr El Aini Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
For scoliotic surgeries, Erector Spinae Plane Block (ESPB) can add to the multimodal approach for perioperative pain management with decreasing the opioids requirement, improving recovery and decreasing ICU stay.
Detailed Description
All patients will be assessed clinically and investigated for Pulmonary function test and Echocardiography. Laboratory work needed will be: Complete blood count (CBC); prothrombin time and concentration (PT& PC); partial thromboplastin time (PTT); bleeding time (BT); clotting time (CT) and liver function tests.
an online randomization program (http://www.randomizer.org) will be used to generate random list and to allocate patients into the two study groups. Random allocation numbers will be concealed in opaque closed envelops.participants and those assessing/analyzing the outcome(s) will be blind to group assignment.
Eutectic Mixture of Local Anesthetics (EMLA) cream will be applied to the site of venous puncture. After insertion of venous access, all children will receive midazolam at a dose of 0.1 mg/Kg. Intraoperative monitoring will include continuous electrocardiogram (ECG), pulse oximetry, invasive arterial blood pressure, end-tidal carbon dioxide (CO2), inhaled gas analyzer and temperature monitoring.
General anesthesia will be induced in both groups (Erector Spinae group and control group) using propofol 2.5 mg/kg over 20-30 seconds, atracurium 0.5 mg/kg to facilitate endotracheal intubation and fentanyl 1 µg/kg. Anesthesia will be maintained using isoflurane (1 MAC) and atracurium infused as 0.5 mg/kg/hr. All patients will receive IV ranitidine 2 mg/kg, ondansetron 0.1 mg/kg, cefotaxime 50 mg/kg and acetaminophen 15 mg/kg. An arterial catheter and a urinary catheter will be placed. Then patients will be turned to the prone position.
In group E: will receive Erector Spinae Plane Block (ESPB) In group C: control group will receive another dose of fentanyl 1 µg/kg 1 minute before start of skin incision. After end of surgery and emergence from anesthesia, patients will receive continuous intravenous morphine with 0.03 mg/kg/hr.
In both groups, if the analgesia obtained from both methods of ESBP or IV fentanyl was inadequate in the form of increase in heart rate and or arterial blood pressure by more than 20% of baseline values during surgery, this warrants the administration of intravenous fentanyl (0.5µg/kg). Total blood loss, duration of surgery, number of vertebral levels fixed, total fentanyl consumed will be recorded. After completion of surgical procedure and emergence from anesthesia the patient will be referred to post-anaesthesia care unit (PACU). Quality of analgesia will be assessed immediately postoperative and then at 4, 8, 12, 16, and 24 hours postoperatively in the Intensive Care Unit (ICU) by using VAS pain score. All patients will receive postoperative IV acetaminophen IV 10 mg/ kg q 6 hours, ketorolac from second day 15 mg q 6 hours, not to exceed 5 days. Patients will also receive ranitidine 2 mg/kg q 12 hours. Vital signs and urinary output will be monitored. Morphine IV will be given as rescue analgesia (20 µg/kg) in all study groups if visual analogue scale (VAS) pain score more than 3. The total maximum hourly morphine is 0.75 mg/kg/hr. After reaching maximum hourly morphine and the patient is still in pain, pethidine will be used as a rescue at 0.5 mg/kg. Morphine will be stopped if maximum hourly dose is reached or the patient becomes sedated (Ramsay score >2), has a ventilatory rate of <12 bpm, or an oxygen saturation of <95%, or has a serious adverse event (allergy, hypotension, severe vomiting).
Patients will be continuously monitored in the PACU and ICU. Naloxone and full resuscitation equipment are available. Time of first need for morphine and total 24 hr morphine consumption will be recorded. Complications e.g nausea, vomiting, pruritis or respiratory depression will be recorded.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Scoliosis Idiopathic, Scoliosis; Adolescence, Erector Spinae Plane Block
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group E
Arm Type
Active Comparator
Arm Description
patients will receive Erector Spinae plane block in addition to intravenous fentanyl
Arm Title
Group C
Arm Type
Other
Arm Description
Control group will receive only intravenous fentanyl.
Intervention Type
Procedure
Intervention Name(s)
Erector Spinae Plane Block
Intervention Description
The linear multi-frequency 6-13 megahertz transducer will be used. In the prone position,under aseptic conditions, the probe will be placed in a longitudinal position 2-3 cm lateral to the vertebral column. The transverse processes of the vertebrae at (mid) level of surgery, the Erector Spinae muscle and the psoas muscle are identified. A 22 gauge echogenic needle will be inserted in an in plane technique in a cephalad to caudad direction until bone contact with the top of the transverse process is reached. After slight retraction of the needle, A test dose of 5% dextrose in water can expand the fascial plane and confirm needle-tip location prior to injection of local anaesthetic. Then, 0.5 ml/kg of bupivacaine 0.25% with 0.1 mg/kg dexamethasone and adrenaline 1 : 200000 will be injected between erector spinea muscle and transverse process, taking in consideration not exceeding the toxic dose of bupivacaine; 4 mg/kg . the same procedure will be repeated on the contralateral side.
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Other Intervention Name(s)
fentanyl for induction and maintenance
Intervention Description
patients will receive an induction dose at 1 mcg/kg. If the analgesia was inadequate in the form of increase in heart rate and or arterial blood pressure by more than 20% of baseline values during surgery, this warrants the administration of intravenous fentanyl (0.5µg/kg).
Intervention Type
Drug
Intervention Name(s)
additional Fentanyl
Intervention Description
patients will receive another dose of fentanyl 1 µg/kg 1 minute before start of skin incision.
Intervention Type
Drug
Intervention Name(s)
Morphine
Other Intervention Name(s)
morphine infusion
Intervention Description
After end of surgery and emergence from anesthesia, patients will receive continuous intravenous morphine with 0.03 mg/kg/hr.
Intervention Type
Drug
Intervention Name(s)
rescue Morphine
Intervention Description
Morphine IV will be given as rescue analgesia (20 µg/kg) in all study groups if VAS pain score more than 3. The total maximum hourly morphine is 0.75 mg/kg/hr.
Intervention Type
Drug
Intervention Name(s)
pethidine
Intervention Description
After reaching maximum hourly morphine and the patient is still in pain, pethidine will be used as a rescue at 0.5 mg/kg.
Intervention Type
Drug
Intervention Name(s)
Ketorolac
Intervention Description
patients will receive IV ketorolac from the postoperative second day 15 mg q 6 hours, not to exceed 5 days.
Intervention Type
Drug
Intervention Name(s)
Acetaminophen
Intervention Description
patients will receive postoperative IV acetaminophen IV 10 mg/ kg q 6 hours
Primary Outcome Measure Information:
Title
Total morphine consumption
Description
Total postoperative rescue morphine consumption in mg/kg for each group in the first 24 hours post-operative period.
Time Frame
the first 24 hours post-operative period.
Secondary Outcome Measure Information:
Title
Total fentanyl consumption
Description
Total intraoperative fentanyl consumption in mcg/kg for each group.
Time Frame
intraoperative period
Title
Visual Analogue Scale
Description
the visual analogue scale (VAS) is for Pain assessment It is a * total 10 cm * linear scale for pain it ranges from minimum ( 0 for no pain at all ) to maximum ( 10 for the worst pain imaginable ) higher number values indicate worst outcome. For example, as the patient mark the scale nearer to maximum, this indicate more severe pain.
Time Frame
the first 24 hours post-operative period.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
American society of Anesthesia classification (ASA) I-II
Patients undergoing dorsal spine instrumentation for scoliosis.
Exclusion Criteria:
Refusal of block.
Bleeding tendency with prothrombin concentration PC less than 75 % or platelet count less than 150,000/µL.
Skin lesion, wounds or infection at the puncture site.
Known allergy to local anaesthetic drugs.
Facility Information:
Facility Name
Cairo University Hospitals
City
Cairo
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Erector Spinae Plane Block in Scoliotic Adolescents
We'll reach out to this number within 24 hrs